Trials / Sponsors / CellCentric Ltd.
CellCentric Ltd.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Multiple Myeloma Refractory, Multiple Myeloma in Relapse | Phase 2 | 2026-01-22 |
| Recruiting | Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma | Phase 1 / Phase 2 | 2019-08-09 |
| Completed | Study to Evaluate CCS1477 in Advanced Tumours Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2018-07-23 |